Akcea Therapeutics, Inc. — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7dfee521-d3cb-49c6-9776-eaa0f7c19e4c/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $38.1M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-008119 |
| FY 2018 | $-230.8M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-005745 |
| FY 2017 | $-120.5M | 2017-01-01 – 2017-12-31 | evidence 0001140361-18-038675 |
| FY 2016 | $-83.5M | 2016-01-01 – 2016-12-31 | evidence 0001662524-18-000007 |
| FY 2015 | $-61.4M | 2015-01-01 – 2015-12-31 | evidence 0001662524-18-000007 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).